Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc.

RXRX
Recursion Pharmaceuticals, Inc.US flagNASDAQ Global Select
3.80
USD
+0.33
- -
1.70BMarket Cap

Income Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
2
3
10
40
44
58
74
+ Sales & Services Revenue
2
3
10
40
44
58
74
- Cost of Revenue
- -
- -
- -
48
43
45
71
+ Cost of Goods & Services
- -
- -
- -
48
43
45
71
Gross Profit
- -
3
10
-9
1
13
3
+ Other Operating Income
-2
- -
- -
- -
- -
- -
- -
- Operating Expenses
64
88
193
237
351
492
651
+ Selling, General & Admin
19
25
58
82
111
178
177
+ Research & Development
46
63
135
156
241
314
475
+ Other Operating Expense
-1
-1
- -
- -
-1
- -
- -
Operating Income (Loss)
-62
-85
-183
-246
-350
-479
-648
- Non-Operating (Income) Loss
-1
2
4
-6
-18
-14
-3
+ Interest Expense, Net
-1
1
3
-6
-19
-14
-21
+ Interest Expense
1
1
3
- -
- -
2
2
- Interest Income
2
- -
- -
6
19
16
23
+ Other Non-Op (Income) Loss
1
1
1
- -
1
- -
18
Pretax Income
-62
-87
-186
-239
-332
-465
-645
- Income Tax Expense (Benefit)
- -
- -
- -
- -
-4
-1
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-62
-87
-186
-239
-328
-464
-645
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-62
-87
-186
-239
-328
-464
-645
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-62
-87
-186
-239
-328
-464
-645
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-62
-87
-186
-239
-328
-464
-645
EBIT
-62
-85
-183
-246
-350
-479
-648
EBITDA
-60
-81
-174
-234
-326
-443
-564
EBITDA Margin (%)
-3,503.92
-2,363.67
-1,743.7
-589.63
-742.22
-756.58
-760.12
EBITA
-62
-85
-183
-246
-350
-479
-648
Gross Margin (%)
100
100
100
-21.66
2.94
22.65
4.45
Operating Margin (%)
-3,649.39
-2,479.2
-1,827.75
-619.26
-797.84
-818.98
-872.83
Profit Margin (%)
-3,616.54
-2,549.25
-1,864.79
-603.5
-747.71
-792.75
-868.29
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
2
4
8
12
24
36
84
Basic Weighted Avg Shares
112
112
125
176
208
274
447
Basic EPS, GAAP
-0.55
-0.77
-1.49
-1.36
-1.58
-1.69
-1.44
Basic EPS from Cont Ops
-0.55
-0.77
-1.49
-1.36
-1.58
-1.69
-1.44
Diluted Weighted Avg Shares
112
112
125
176
208
274
447
Diluted EPS, GAAP
-0.55
-0.77
-1.49
-1.36
-1.58
-1.69
-1.44
Diluted EPS from Cont Ops
-0.55
-0.77
-1.49
-1.36
-1.58
-1.69
-1.44

Balance Sheet (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
76
266
535
570
438
714
813
+ Cash, Cash Equivalents & STI
70
262
517
550
392
594
743
+ Cash & Cash Equivalents
70
262
285
550
392
594
743
+ ST Investments
- -
- -
231
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
9
3
3
49
25
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
9
3
3
49
25
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
6
4
9
17
43
71
45
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
25
32
76
131
216
734
661
+ Property, Plant & Equip, Net
24
26
65
121
120
233
169
+ Property, Plant & Equip
30
36
83
152
165
296
259
- Accumulated Depreciation
6
10
19
30
45
63
89
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
1
6
11
10
95
501
492
+ Total Intangible Assets
- -
2
2
2
88
485
472
+ Goodwill
- -
1
1
1
52
149
162
+ Other Intangible Assets
- -
2
1
1
36
336
310
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
1
4
9
8
7
16
20
Total Assets
101
299
610
701
654
1,449
1,474
+ Payables & Accruals
4
8
23
17
28
53
57
+ Accounts Payable
1
1
3
5
4
22
18
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
3
7
21
12
24
31
38
+ ST Debt
1
2
2
6
6
22
22
+ ST Borrowings
- -
1
- -
- -
- -
8
9
+ ST Finance Leases
- -
- -
1
6
6
14
13
+ Other ST Liabilities
2
13
22
77
59
113
69
+ Deferred Revenue
- -
10
10
57
36
62
38
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
2
3
12
20
23
51
32
Total Current Liabilities
7
23
47
100
93
187
148
+ LT Debt
16
14
10
45
45
86
56
+ LT Borrowings
12
11
1
1
1
19
10
+ LT Finance Leases
3
3
9
44
43
67
47
+ Other LT Liabilities
203
468
11
70
53
140
139
+ Accrued Liabilities
2
19
11
70
53
135
137
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
201
448
- -
- -
- -
5
2
Total Noncurrent Liabilities
219
482
21
115
97
226
196
Total Liabilities
226
505
67
215
190
414
343
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
2
7
943
1,125
1,431
2,474
3,170
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
2
7
943
1,125
1,431
2,474
3,170
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-127
-214
-400
-640
-968
-1,431
-2,076
+ Other Equity
- -
- -
- -
- -
- -
-8
37
Equity Before Minority Interest
-124
-206
543
486
463
1,035
1,131
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-124
-206
543
486
463
1,035
1,131
Total Liabilities & Equity
101
299
610
701
654
1,449
1,474
Shares Outstanding
156
156
170
191
234
397
528
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
4
3
11
50
50
81
59
Net Debt
-57
-250
-284
-549
-390
-567
-725
Net Debt to Equity
46.18
121.01
-52.38
-113.07
-84.25
-54.78
-64.08
Tangible Common Equity Ratio
-122.51
-70.51
88.92
69.18
66.34
57.07
65.74
Current Ratio
11.43
11.53
11.46
5.68
4.7
3.81
5.5
Cash Conversion Cycle
- -
- -
- -
-27.84
-36.59
-103.14
-102.19

Cash Flow Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-62
-87
-186
-239
-328
-464
-645
+ Depreciation & Amortization
2
4
8
12
24
36
84
+ Non-Cash Items
2
7
20
39
60
115
176
+ Stock-Based Compensation
1
4
15
28
54
82
111
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
1
- -
3
1
- -
6
+ Other Non-Cash Adj
1
2
5
9
5
33
58
+ Chg in Non-Cash Work Cap
- -
31
- -
105
-44
-47
14
+ (Inc) Dec in Accts Receiv
1
-1
-5
- -
-8
-6
33
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
6
-9
50
+ Inc (Dec) in Accts Payable
- -
5
15
2
8
12
-12
+ Inc (Dec) in Other
- -
27
-10
103
-51
-44
-57
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-57
-45
-159
-84
-288
-359
-372
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-4
-7
-40
-37
-13
-17
-9
+ Acq of Fixed Prod Assets
-4
-6
-40
-37
-12
-14
-6
+ Acq of Intangible Assets
- -
-1
- -
- -
-1
-3
-2
+ Cash (Repurchase) of Equity
- -
- -
463
144
128
300
529
+ Increase in Capital Stock
- -
- -
463
144
128
300
529
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-232
231
- -
- -
-4
+ Dec in LT Investment
- -
- -
69
231
- -
- -
- -
+ Inc in LT Investment
- -
- -
-301
- -
- -
- -
-4
+ Net Cash From Acq & Div
- -
-3
- -
- -
2
277
-4
+ Cash from Divestitures
- -
- -
- -
- -
2
277
- -
+ Cash for Acq of Subs
- -
-3
- -
- -
- -
- -
-4
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
1
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-4
-9
-272
193
-10
260
-17
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
1
6
-13
- -
-1
-4
-8
+ Cash From Debt
12
6
- -
- -
- -
- -
- -
+ Repayments of Debt
-11
- -
-13
- -
-1
-4
-8
+ Other Financing Activities
120
240
8
11
13
8
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
120
246
459
154
140
304
522
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
-3
18
Net Changes in Cash
59
192
28
264
-158
205
133
EBITDA
-60
-81
-174
-234
-326
-443
-564
EBITDA Margin (%)
-3,503.92
-2,363.67
-1,743.7
-589.63
-742.22
-756.58
-760.12
Free Cash Flow
-61
-52
-198
-121
-300
-376
-380
Net Cash Paid for Acquisitions
- -
3
- -
- -
-2
-277
4
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-45
-211
-121
-301
-377
-387
Free Cash Flow per Basic Share
-0.54
-0.46
-1.58
-0.69
-1.44
-1.37
-0.85
Price/Free Cash Flow
- -
- -
-18.07
-29.32
-7.45
-5.42
-5.04
Cash Flow to Net Income
0.92
0.52
0.85
0.35
0.88
0.77
0.58
Capital Expenditures
-4
-7
-40
-37
-13
-17
-9